| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.23 | 0.09 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |